Adding Multiparametric MRI to Prostate Cancer Screening Will Save Lives and Money
Adding Multiparametric MRI to Prostate Cancer Screening Will Save Lives and Money
In recent years, recommendations for prostate cancer screening have been caught amidst growing controversy. The utility of prostate-specific antigen (PSA) testing, the most prominent front-line screening exam for prostate cancer has been heavily critiqued. Meanwhile, numerous men present with incurable late-stage prostate cancer while men with low-risk, indolent disease receive treatment that offers little benefit in terms of health outcomes.